{"id":"W4311675987","doi":"10.1200/jco.22.01064","title":"Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":154,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Partnership Against Cancer; University of Calgary","funders":"Eisai; National Cancer Institute; Cancer Research UK; AstraZeneca; Ipsen; Pfizer","keywords":"Exemestane; Medicine; Breast cancer; Internal medicine; Tamoxifen; Hazard ratio; Oncology; Population; Gynecology; Clinical endpoint; Cancer; Clinical trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02766109,0.001014,0.004164205,0.001337402,0.0006772233,0.002320897,0.0005569108,0.001830062,0.003249642],"category_scores_gemma":[0.03433451,0.0004937375,0.006104238,0.002101073,0.0006297643,0.002649955,0.001251134,0.002297732,0.0007525474],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007866541,"about_ca_system_score_gemma":0.001188981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005699652,"about_ca_topic_score_gemma":0.001257401,"domain_scores_codex":[0.9860541,0.01008078,0.001459201,0.000669426,0.001231134,0.0005052353],"domain_scores_gemma":[0.9685583,0.01443712,0.009936833,0.003180546,0.002159746,0.001727456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7844023,0.002614346,0.01940235,0.005376901,0.02296099,0.0001470378,0.0001689969,0.001167308,0.002776578,0.0003650922,0.003328292,0.1572899],"study_design_scores_gemma":[0.3358035,0.3064011,0.2286758,0.004739941,0.08497677,0.0007883295,0.0004085796,0.005371085,0.006319849,0.003950594,0.02230142,0.0002629965],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8649254,0.10621,0.004175165,0.002735433,0.001448315,0.005127976,0.006181542,0.0002376494,0.008958509],"genre_scores_gemma":[0.9682698,0.009742821,0.002898215,0.001890088,0.001478273,0.005588731,0.006681051,0.00005512847,0.003395939],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02766109,"threshold_uncertainty_score":0.1462876,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03948734879092645,"score_gpt":0.3826867006329955,"score_spread":0.3431993518420691,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}